Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease.

More information Original publication

DOI

10.1038/s41467-021-22491-8

Type

Journal article

Publication Date

2021-06-01T00:00:00+00:00

Volume

12

Addresses

R, e, s, e, a, r, c, h, , C, e, n, t, e, r, , a, n, d, , M, e, m, o, r, y, , c, l, i, n, i, c, , F, u, n, d, a, c, i, ó, , A, C, E, ,, , I, n, s, t, i, t, u, t, , C, a, t, a, l, à, , d, e, , N, e, u, r, o, c, i, è, n, c, i, e, s, , A, p, l, i, c, a, d, e, s, ,, , U, n, i, v, e, r, s, i, t, a, t, , I, n, t, e, r, n, a, c, i, o, n, a, l, , d, e, , C, a, t, a, l, u, n, y, a, ,, , B, a, r, c, e, l, o, n, a, ,, , S, p, a, i, n, .

Keywords

EADB contributors, GR@ACE study group, DEGESCO consortium, IGAP (ADGC, CHARGE, EADI, GERAD), PGC-ALZ consortia, Humans, Alzheimer Disease, Genetic Predisposition to Disease, Amyloid beta-Protein Precursor, Apolipoproteins E, Risk Assessment, Risk Factors, Case-Control Studies, Cohort Studies, Follow-Up Studies, Age of Onset, Heterozygote, Multifactorial Inheritance, Polymorphism, Single Nucleotide, Aged, Aged, 80 and over, Middle Aged, Female, Male, Genome-Wide Association Study, Datasets as Topic